Pfizer Limited (NSE:PFIZER)

Market Cap	223.92B +22.1%
Revenue (ttm)	24.82B +11.0%
Net Income	8.54B +38.7%
EPS	186.59 +38.7%
Shares Out	45.75M
PE Ratio	26.23
Forward PE	26.59
Dividend	35.00 (0.72%)
Ex-Dividend Date	Jul 9, 2025

Volume	6,022
Average Volume	13,731
Open	4,913.00
Previous Close	4,894.70
Day's Range	4,837.20 - 4,917.20
52-Week Range	4,100.10 - 5,993.00
Beta	0.17
RSI	53.69
Earnings Date	May 30, 2026

About Pfizer

Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a netwo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1950
• Employees: 1,598
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: PFIZER

Financial Performance

In fiscal year 2025, Pfizer's revenue was 22.81 billion, an increase of 4.02% compared to the previous year's 21.93 billion. Earnings were 7.68 billion, an increase of 39.23%.